|
|
Volumn 8, Issue 6, 2004, Pages 629-637
|
|
Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANASTROZOLE;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE INHIBITOR;
DRUG DERIVATIVE;
ESTRADIOL;
FULVESTRANT;
LETROZOLE;
NITRILE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TRIAZOLE DERIVATIVE;
ALGORITHM;
BREAST TUMOR;
CLASSIFICATION;
DECISION TREE;
DRUG ADMINISTRATION;
DRUG MONITORING;
FEMALE;
HUMAN;
METHODOLOGY;
NURSE ATTITUDE;
NURSING;
ONCOLOGY NURSING;
PATIENT EDUCATION;
PATIENT SELECTION;
POSTMENOPAUSE;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
REVIEW;
SAFETY;
SOCIAL SUPPORT;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ALGORITHMS;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
DECISION TREES;
DRUG ADMINISTRATION SCHEDULE;
DRUG MONITORING;
ESTRADIOL;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NITRILES;
NURSE'S ROLE;
ONCOLOGIC NURSING;
PATIENT EDUCATION;
PATIENT SELECTION;
POSTMENOPAUSE;
QUALITY OF LIFE;
SAFETY;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
SOCIAL SUPPORT;
TAMOXIFEN;
TREATMENT OUTCOME;
TRIAZOLES;
|
|
EID: 13744255584
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/04.CJON.629-637 Document Type: Review |
|
Times cited : (11)
|
|
References (69)
|
